Specialized medical Efficiency associated with Follitropin Alfa within GnRH-Antagonist Protocols: A Prospective Observational Phase 4 Study using Biosimilar Follitropin Alfa r-hFSH inside Helped Reproductive Technology in a Program Treatment Environment.